The statistic shows the market capitalization of health care subsectors in Australia as of August 2015, measured in Australian dollars. According to the Australian Stock Exchange, biotechnology was the subsector with the largest market cap. However, over 90 percent of the industry's total market cap of 47.3 billion dollars was due to Australia's most successful biotech company CSL.
Market capitalization of health care subsectors in Australia as of 2015 (in Australian dollars)*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Basic Statistic Share of total business expenditure on technology R&D in Australia 2014
- Premium Statistic Biotech industry growth rates in Australia compared to worldwide 2016
- Premium Statistic Number of active clinical trials and studies in Australia by therapeutic class 2014
- Basic Statistic Projection of top therapeutic areas by sales worldwide 2019
- Basic Statistic Projected 2024 revenue for top drugs approved U.S. 2018
- Premium Statistic Projected 2019 revenue for top drugs approved U.S. 2014
- Premium Statistic Top U.S. pharmaceutical patent expiries by revenue 2014-2016
- Basic Statistic Projected 2018 revenue for top 10 drugs approved U.S. 2013
- Basic Statistic Gilead Sciences' net income 2006-2023
About the region
10
- Premium Statistic Total medical equipment market size in Australia 2014-2023
- Premium Statistic Local medical equipment production value in Australia 2014-2023
- Premium Statistic Trade of medical equipment Australia 2014-2023
- Basic Statistic Annual revenue of pharmaceutical, cosmetic, and toiletry retail Australia 2014-2023
- Premium Statistic Number of pharmacists in Australia 2022, by registration type
- Basic Statistic Number of pharmaceutical and cosmetic businesses Australia FY 2023, by state
- Premium Statistic Value of pharmaceutical product exports in Australia 2008-2019
- Premium Statistic Value of pharmaceutical product imports in Australia 2008-2019
- Premium Statistic Business expenditure of ICT sector on research and development Australia FY 2018
- Premium Statistic Import value of ICT services Australia FY 2013-2020
Selected statistics
10
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Merck & Co cash dividends declared 2006-2023
Other regions
10
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Revenue value from biotechnology companies in Germany 2008-2022
- Basic Statistic Projected most valuable R&D projects based on net present value 2023
- Premium Statistic Projection of top 2024 pharma and biotech launches by revenue 2028
- Premium Statistic Market size of biopharmaceuticals in China 2013-20225
- Premium Statistic European public biotech companies - key figures 2012-2016
- Premium Statistic Canadian biotech public companies - key figures 2012-2014
- Premium Statistic Patients in clinical trials in selected European countries 2005-2011
- Basic Statistic Pharmaceutical revenue as percent of health spending in African major countries 2014
- Premium Statistic Pharmaceutical revenue as percent of health expenditure by Asian country 2014
Related statistics
10
- Premium Statistic Value of monthly exports of medical and pharmaceutical products Australia 2020-2023
- Premium Statistic Leading pharmaceutical companies listed on ASX Australia 2023
- Premium Statistic Leading biotechnology companies listed on ASX Australia 2023
- Premium Statistic Value of monthly imports of medical and pharmaceutical products Australia 2020-2023
- Basic Statistic Annual revenue of pharmaceutical and cosmetic goods retail Australia 2011-2022
- Premium Statistic Subsidized drug expenditure in Australia FY 2016-2022
- Premium Statistic Revenue of Australian Pharmaceutical Industries Limited 2015-2021
- Premium Statistic Most commonly used prescription drugs Australia FY 2023
- Premium Statistic Most expensive prescription drugs Australia FY 2021, by cost to government
- Premium Statistic Most prescribed prescription drugs Australia FY 2021, by prescriptions
Further related statistics
10
- Key figures on established biotech centers worldwide 2012-2016
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Expenditure worldwide on diabetes by market 2013-2018
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
Further Content: You might find this interesting as well
Statistics
- Key figures on established biotech centers worldwide 2012-2016
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Expenditure worldwide on diabetes by market 2013-2018
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
McKell Institute. (October 26, 2016). Market capitalization of health care subsectors in Australia as of 2015 (in Australian dollars)* [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/717381/market-cap-of-health-care-subsectors-in-australia/
McKell Institute. "Market capitalization of health care subsectors in Australia as of 2015 (in Australian dollars)*." Chart. October 26, 2016. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/717381/market-cap-of-health-care-subsectors-in-australia/
McKell Institute. (2016). Market capitalization of health care subsectors in Australia as of 2015 (in Australian dollars)*. Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/717381/market-cap-of-health-care-subsectors-in-australia/
McKell Institute. "Market Capitalization of Health Care Subsectors in Australia as of 2015 (in Australian Dollars)*." Statista, Statista Inc., 26 Oct 2016, https://www.statista.com/statistics/717381/market-cap-of-health-care-subsectors-in-australia/
McKell Institute, Market capitalization of health care subsectors in Australia as of 2015 (in Australian dollars)* Statista, https://www.statista.com/statistics/717381/market-cap-of-health-care-subsectors-in-australia/ (last visited June 01, 2024)
Market capitalization of health care subsectors in Australia as of 2015 (in Australian dollars)* [Graph], McKell Institute, October 26, 2016. [Online]. Available: https://www.statista.com/statistics/717381/market-cap-of-health-care-subsectors-in-australia/